UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000010812
Receipt No. R000012080
Official scientific title of the study A study of interferon beta/ ribavirin plus non-activated vitamin D combination therapy for chronic hepatitis C and decompensated cirrhosis patients.
Date of disclosure of the study information 2013/05/27
Last modified on 2018/09/21 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A study of interferon beta/ ribavirin plus non-activated vitamin D combination therapy for chronic hepatitis C and decompensated cirrhosis patients.
Title of the study (Brief title) Interferon beta with/without ribavirin plus non-activated vitamin D combination therapy for chronic hepatitis C and decompensated cirrhosis patients.
Region
Japan

Condition
Condition Chronic hepatitis C patients and compensated cirrhosis patients
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 To verify whether can be improved therapeutic effect by the combined use of non-activated vitamin D to IFN beta or IFN beta / RBV, for chronic hepatitis C and compensated cirrhosis patients.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Negative result of HCV RNA test at 24 weeks after therapy.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine Food
Interventions/Control_1 Chronic hepatitis C with high viral load:
Vitamin D(2000IU/day)for 4 weeks, vitamin D, IFN-beta(6 MIU)and ribavirin(600-1000mg/day)for 48 weeks. Negative result of HCV RNA test at 12-36 weeks for 72 weeks treatment.
HCV serogroup 2 patients were treatment for 24 weeks.

Chronic hepatitis C with low viral load :retreatment patients:
Vitamin D(2000IU/day)for 4 weeks, vitamin D, IFN-beta(6 MIU) and ribavirin(600-1000mg/day)for 24 weeks.

Chronic hepatitis C with low viral load:naive patients:
Vitamin D(2000IU/day)for 4 weeks, vitamin D and IFN-beta(6 MIU) for 8-24 weeks.

Compensated cirrhosis patients:
Vitamin D(2000IU/day)for 4 weeks, vitamin D and IFN-beta(6 MIU) for 36 weeks.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Chronic hepatitis C and compensated cirrhosis patients with serogroup 1 and low viral load, with serogroup 2.
Key exclusion criteria pregnant women and nursing mothers
Target sample size 60

Research contact person
Name of lead principal investigator Satoshi Mochida
Organization Saitama Medical University
Division name Division of Gastroenterology and Hepatology ,internal Medicine
Address 38,Morohongou,Moroyama-machi,Iruma-gun,Saitama,Japan
TEL 049-276-1111
Email hirb@saitama-med.ac.jp

Public contact
Name of contact person Nobuaki Nakayama
Organization Saitama Medical University
Division name Division of Gastroenterology and Hepatology ,internal Medicine
Address 38,Morohongou,Moroyama-machi,Iruma-gun,Saitama,Japan
TEL 049-276-1111
Homepage URL
Email hirb@saitama-med.ac.jp

Sponsor
Institute Saitama Medical University
Institute
Department

Funding Source
Organization Saitama Medical University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 05 Month 27 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 05 Month 13 Day
Anticipated trial start date
2013 Year 05 Month 13 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 05 Month 27 Day
Last modified on
2018 Year 09 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000012080